Last edition
News about "BARDA funding"
US FDA Approves Utebzi for Adult Patients with Complicated UTIs
The US Food and Drug Administration (FDA) has approved GSK’s Utebzi (tebipenem pivoxil) for adults with complicated Urinary Tract Infections (cUTIs), becoming the first and only oral carbapenem antibiotic available. The approval is based on the phase 3 PIVOT-PO trial, which demonstrated non-inferiority to standard intravenous antibiotic treatment.
BARDA Funding | 19/06/2026 | By News Bureau
SCHOTT Pharma Expands Vial Manufacturing Capacity in Lebanon
SCHOTT Pharma inaugurates new capacity for core and specialty vials at its site in Lebanon, supporting future growth in the region. The state-of-the-art equipment sets new quality and automation standards for High-Value Solutions (HVS) in the US.
BARDA Funding | 04/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy